Literature DB >> 15952797

Design of peptidyl compounds that affect beta-amyloid aggregation: importance of surface tension and context.

Todd J Gibson1, Regina M Murphy.   

Abstract

Self-association of beta-amyloid (Abeta) peptide into cross-beta-sheet fibrils induces cellular toxicity in vitro and is linked with progression of Alzheimer's disease. Previously, we demonstrated that hybrid peptides, containing a recognition domain that binds to Abeta and a disrupting domain consisting of a chain of charged amino acids, inhibited Abeta-associated toxicity in vitro and increased the rate of Abeta aggregation. In this work we examine the design parameter space of the disrupting domain. Using KLVFFKKKKKK as a base case, we tested hybrid compounds with a branched rather than linear lysine oligomer, with l-lysine replaced by d-lysine, and with lysine replaced by diaminopropionic acid. We synthesized a compound with a novel anionic disrupting domain that contained cysteine thiols oxidized to sulfates, as well as other compounds in which alkyl or ether chains were appended to KLVFF. In all cases, the hybrid compound's ability to increase solvent surface tension was the strongest predictor of its effect on Abeta aggregation kinetics. Finally, we investigated the effects of arginine on Abeta aggregation. Arginine is a well-known chaotrope but increases surface tension of water. Arginine modestly decreased Abeta aggregation. In contrast, RRRRRR slightly, and KLVFFRRRRRR greatly, increased Abeta aggregation. Thus, the influence of arginine on Abeta aggregation depends strongly on the context in which it is presented. The effect of arginine, RRRRRR, and KLVFFRRRRRR on Abeta aggregation was examined in detail using laser light scattering, circular dichroism spectroscopy, Fourier transform infrared spectroscopy, thioflavin T fluorescence, and transmission electron microscopy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15952797     DOI: 10.1021/bi050225s

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  11 in total

1.  Inhibition of insulin fibrillogenesis with targeted peptides.

Authors:  Todd J Gibson; Regina M Murphy
Journal:  Protein Sci       Date:  2006-04-05       Impact factor: 6.725

2.  Nonnative protein polymers: structure, morphology, and relation to nucleation and growth.

Authors:  William F Weiss; Travis K Hodgdon; Eric W Kaler; Abraham M Lenhoff; Christopher J Roberts
Journal:  Biophys J       Date:  2007-08-17       Impact factor: 4.033

3.  Lumry-Eyring nucleated-polymerization model of protein aggregation kinetics. 2. Competing growth via condensation and chain polymerization.

Authors:  Yi Li; Christopher J Roberts
Journal:  J Phys Chem B       Date:  2009-05-14       Impact factor: 2.991

Review 4.  The role of molecular simulations in the development of inhibitors of amyloid β-peptide aggregation for the treatment of Alzheimer's disease.

Authors:  Justin A Lemkul; David R Bevan
Journal:  ACS Chem Neurosci       Date:  2012-08-27       Impact factor: 4.418

Review 5.  Peptides for therapy and diagnosis of Alzheimer's disease.

Authors:  Susanne Aileen Funke; Dieter Willbold
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

6.  Rationally designed peptidomimetic modulators of aβ toxicity in Alzheimer's disease.

Authors:  K Rajasekhar; S N Suresh; Ravi Manjithaya; T Govindaraju
Journal:  Sci Rep       Date:  2015-01-30       Impact factor: 4.379

7.  Propagation of Fibrillar Structural Forms in Proteins Stopped by Naturally Occurring Short Polypeptide Chain Fragments.

Authors:  Irena Roterman; Mateusz Banach; Leszek Konieczny
Journal:  Pharmaceuticals (Basel)       Date:  2017-11-16

8.  Towards the design of anti-amyloid short peptide helices.

Authors:  Irena Roterman; Mateusz Banach; Leszek Konieczny
Journal:  Bioinformation       Date:  2018-01-31

9.  Proteomic analysis of cortical neuronal cultures treated with poly-arginine peptide-18 (R18) and exposed to glutamic acid excitotoxicity.

Authors:  Gabriella MacDougall; Ryan S Anderton; Frank L Mastaglia; Neville W Knuckey; Bruno P Meloni
Journal:  Mol Brain       Date:  2019-07-17       Impact factor: 4.041

10.  Computational design of new Peptide inhibitors for amyloid Beta (aβ) aggregation in Alzheimer's disease: application of a novel methodology.

Authors:  Gözde Eskici; Mert Gur
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.